Ht-Logo-gigapixel-icon
Thursday, November 21, 2024
Canada’s Politics and Government News Source Since 1989
Thursday, November 21, 2024 | Latest Paper

David Renwick

A year later, none of the $1.5B for rare disease has flowed to patients

Opinion | BY DAVID RENWICK | February 28, 2024
Mark Holland
Health Minister Mark Holland speaks to reporters in West Block on Jan. 31. Bilateral agreements to transfer funds under the National Strategy for Drugs for Rare Diseases to increase drug access as well as diagnostic and screening capacity haven’t yet been signed, writes David Renwick. The Hill Times photograph by Andrew Meade
Opinion | BY DAVID RENWICK | February 28, 2024
Opinion | BY DAVID RENWICK | February 28, 2024
Mark Holland
Health Minister Mark Holland speaks to reporters in West Block on Jan. 31. Bilateral agreements to transfer funds under the National Strategy for Drugs for Rare Diseases to increase drug access as well as diagnostic and screening capacity haven’t yet been signed, writes David Renwick. The Hill Times photograph by Andrew Meade
Opinion | BY DAVID RENWICK | February 28, 2024
Mark Holland
Health Minister Mark Holland speaks to reporters in West Block on Jan. 31. Bilateral agreements to transfer funds under the National Strategy for Drugs for Rare Diseases to increase drug access as well as diagnostic and screening capacity haven’t yet been signed, writes David Renwick. The Hill Times photograph by Andrew Meade
Opinion | BY DAVID RENWICK | February 28, 2024
Opinion | BY DAVID RENWICK | February 28, 2024
Mark Holland
Health Minister Mark Holland speaks to reporters in West Block on Jan. 31. Bilateral agreements to transfer funds under the National Strategy for Drugs for Rare Diseases to increase drug access as well as diagnostic and screening capacity haven’t yet been signed, writes David Renwick. The Hill Times photograph by Andrew Meade